nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—CYP2E1—type 2 diabetes mellitus	0.316	1	CbGaD
Meprobamate—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0501	0.119	CbGbCtD
Meprobamate—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.047	0.112	CbGbCtD
Meprobamate—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0446	0.106	CbGbCtD
Meprobamate—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.04	0.0953	CbGbCtD
Meprobamate—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.04	0.0953	CbGbCtD
Meprobamate—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0369	0.088	CbGbCtD
Meprobamate—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0357	0.085	CbGbCtD
Meprobamate—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0323	0.0769	CbGbCtD
Meprobamate—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0222	0.0528	CbGbCtD
Meprobamate—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0205	0.0488	CbGbCtD
Meprobamate—CYP2C19—Losartan—type 2 diabetes mellitus	0.0187	0.0446	CbGbCtD
Meprobamate—ABCB1—Glyburide—type 2 diabetes mellitus	0.0165	0.0394	CbGbCtD
Meprobamate—ABCB1—Losartan—type 2 diabetes mellitus	0.0151	0.036	CbGbCtD
Meprobamate—Syncope—Bromocriptine—type 2 diabetes mellitus	0.000473	0.00267	CcSEcCtD
Meprobamate—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000472	0.00266	CcSEcCtD
Meprobamate—Vomiting—Acarbose—type 2 diabetes mellitus	0.000471	0.00265	CcSEcCtD
Meprobamate—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.00047	0.00265	CcSEcCtD
Meprobamate—Shock—Glimepiride—type 2 diabetes mellitus	0.00047	0.00265	CcSEcCtD
Meprobamate—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000467	0.00263	CcSEcCtD
Meprobamate—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000466	0.00263	CcSEcCtD
Meprobamate—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.000464	0.00261	CcSEcCtD
Meprobamate—Drowsiness—Metformin—type 2 diabetes mellitus	0.000464	0.00261	CcSEcCtD
Meprobamate—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000459	0.00259	CcSEcCtD
Meprobamate—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000458	0.00258	CcSEcCtD
Meprobamate—Nausea—Tolazamide—type 2 diabetes mellitus	0.000458	0.00258	CcSEcCtD
Meprobamate—Eosinophilia—Losartan—type 2 diabetes mellitus	0.000457	0.00258	CcSEcCtD
Meprobamate—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000455	0.00257	CcSEcCtD
Meprobamate—Somnolence—Glipizide—type 2 diabetes mellitus	0.000455	0.00256	CcSEcCtD
Meprobamate—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000454	0.00256	CcSEcCtD
Meprobamate—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00045	0.00254	CcSEcCtD
Meprobamate—Chills—Gliclazide—type 2 diabetes mellitus	0.000446	0.00252	CcSEcCtD
Meprobamate—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000446	0.00251	CcSEcCtD
Meprobamate—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.000445	0.00251	CcSEcCtD
Meprobamate—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000444	0.0025	CcSEcCtD
Meprobamate—Angioedema—Glyburide—type 2 diabetes mellitus	0.000441	0.00248	CcSEcCtD
Meprobamate—Nausea—Acarbose—type 2 diabetes mellitus	0.00044	0.00248	CcSEcCtD
Meprobamate—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000437	0.00246	CcSEcCtD
Meprobamate—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000432	0.00243	CcSEcCtD
Meprobamate—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000429	0.00242	CcSEcCtD
Meprobamate—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000424	0.00239	CcSEcCtD
Meprobamate—Nausea—Nateglinide—type 2 diabetes mellitus	0.000424	0.00239	CcSEcCtD
Meprobamate—Shock—Bromocriptine—type 2 diabetes mellitus	0.000424	0.00239	CcSEcCtD
Meprobamate—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000423	0.00238	CcSEcCtD
Meprobamate—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000423	0.00238	CcSEcCtD
Meprobamate—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00042	0.00237	CcSEcCtD
Meprobamate—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000419	0.00236	CcSEcCtD
Meprobamate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000413	0.00233	CcSEcCtD
Meprobamate—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.00041	0.00231	CcSEcCtD
Meprobamate—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000408	0.0023	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000408	0.0023	CcSEcCtD
Meprobamate—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000402	0.00227	CcSEcCtD
Meprobamate—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.0004	0.00225	CcSEcCtD
Meprobamate—Agitation—Gliclazide—type 2 diabetes mellitus	0.000398	0.00224	CcSEcCtD
Meprobamate—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000396	0.00223	CcSEcCtD
Meprobamate—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000393	0.00221	CcSEcCtD
Meprobamate—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000392	0.00221	CcSEcCtD
Meprobamate—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00039	0.0022	CcSEcCtD
Meprobamate—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000389	0.00219	CcSEcCtD
Meprobamate—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000388	0.00218	CcSEcCtD
Meprobamate—Headache—Repaglinide—type 2 diabetes mellitus	0.000387	0.00218	CcSEcCtD
Meprobamate—Shock—Glyburide—type 2 diabetes mellitus	0.000387	0.00218	CcSEcCtD
Meprobamate—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000387	0.00218	CcSEcCtD
Meprobamate—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000387	0.00218	CcSEcCtD
Meprobamate—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000386	0.00218	CcSEcCtD
Meprobamate—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000384	0.00217	CcSEcCtD
Meprobamate—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000383	0.00216	CcSEcCtD
Meprobamate—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000383	0.00216	CcSEcCtD
Meprobamate—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000381	0.00215	CcSEcCtD
Meprobamate—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000377	0.00212	CcSEcCtD
Meprobamate—Chills—Metformin—type 2 diabetes mellitus	0.000373	0.0021	CcSEcCtD
Meprobamate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000368	0.00207	CcSEcCtD
Meprobamate—Hypotension—Glyburide—type 2 diabetes mellitus	0.000368	0.00207	CcSEcCtD
Meprobamate—Nausea—Repaglinide—type 2 diabetes mellitus	0.000367	0.00207	CcSEcCtD
Meprobamate—Asthenia—Glipizide—type 2 diabetes mellitus	0.000367	0.00207	CcSEcCtD
Meprobamate—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000366	0.00206	CcSEcCtD
Meprobamate—Angioedema—Valsartan—type 2 diabetes mellitus	0.000364	0.00205	CcSEcCtD
Meprobamate—Pruritus—Glipizide—type 2 diabetes mellitus	0.000362	0.00204	CcSEcCtD
Meprobamate—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000361	0.00203	CcSEcCtD
Meprobamate—Angioedema—Orlistat—type 2 diabetes mellitus	0.000359	0.00202	CcSEcCtD
Meprobamate—Vertigo—Valsartan—type 2 diabetes mellitus	0.000357	0.00201	CcSEcCtD
Meprobamate—Syncope—Valsartan—type 2 diabetes mellitus	0.000357	0.00201	CcSEcCtD
Meprobamate—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000353	0.00199	CcSEcCtD
Meprobamate—Vertigo—Orlistat—type 2 diabetes mellitus	0.000353	0.00199	CcSEcCtD
Meprobamate—Chills—Irbesartan—type 2 diabetes mellitus	0.000352	0.00199	CcSEcCtD
Meprobamate—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000352	0.00198	CcSEcCtD
Meprobamate—Palpitations—Valsartan—type 2 diabetes mellitus	0.000352	0.00198	CcSEcCtD
Meprobamate—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000352	0.00198	CcSEcCtD
Meprobamate—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000351	0.00198	CcSEcCtD
Meprobamate—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000351	0.00198	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.00035	0.00197	CcSEcCtD
Meprobamate—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00035	0.00197	CcSEcCtD
Meprobamate—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00035	0.00197	CcSEcCtD
Meprobamate—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.00035	0.00197	CcSEcCtD
Meprobamate—Palpitations—Orlistat—type 2 diabetes mellitus	0.000347	0.00196	CcSEcCtD
Meprobamate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000347	0.00196	CcSEcCtD
Meprobamate—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000345	0.00194	CcSEcCtD
Meprobamate—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000344	0.00194	CcSEcCtD
Meprobamate—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000342	0.00193	CcSEcCtD
Meprobamate—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000341	0.00192	CcSEcCtD
Meprobamate—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00034	0.00192	CcSEcCtD
Meprobamate—Dizziness—Glipizide—type 2 diabetes mellitus	0.000338	0.00191	CcSEcCtD
Meprobamate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000338	0.0019	CcSEcCtD
Meprobamate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000335	0.00189	CcSEcCtD
Meprobamate—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00033	0.00186	CcSEcCtD
Meprobamate—Arrhythmia—Losartan—type 2 diabetes mellitus	0.00033	0.00186	CcSEcCtD
Meprobamate—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.00033	0.00186	CcSEcCtD
Meprobamate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000327	0.00184	CcSEcCtD
Meprobamate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000326	0.00183	CcSEcCtD
Meprobamate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000325	0.00183	CcSEcCtD
Meprobamate—Syncope—Metformin—type 2 diabetes mellitus	0.000325	0.00183	CcSEcCtD
Meprobamate—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000325	0.00183	CcSEcCtD
Meprobamate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000324	0.00183	CcSEcCtD
Meprobamate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000322	0.00182	CcSEcCtD
Meprobamate—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000321	0.00181	CcSEcCtD
Meprobamate—Headache—Glipizide—type 2 diabetes mellitus	0.00032	0.00181	CcSEcCtD
Meprobamate—Palpitations—Metformin—type 2 diabetes mellitus	0.00032	0.0018	CcSEcCtD
Meprobamate—Shock—Valsartan—type 2 diabetes mellitus	0.000319	0.0018	CcSEcCtD
Meprobamate—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000318	0.00179	CcSEcCtD
Meprobamate—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000317	0.00179	CcSEcCtD
Meprobamate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000316	0.00178	CcSEcCtD
Meprobamate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000315	0.00177	CcSEcCtD
Meprobamate—Agitation—Irbesartan—type 2 diabetes mellitus	0.000314	0.00177	CcSEcCtD
Meprobamate—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000314	0.00177	CcSEcCtD
Meprobamate—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000312	0.00176	CcSEcCtD
Meprobamate—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000312	0.00176	CcSEcCtD
Meprobamate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000309	0.00174	CcSEcCtD
Meprobamate—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000307	0.00173	CcSEcCtD
Meprobamate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000307	0.00173	CcSEcCtD
Meprobamate—Syncope—Irbesartan—type 2 diabetes mellitus	0.000307	0.00173	CcSEcCtD
Meprobamate—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000306	0.00172	CcSEcCtD
Meprobamate—Nausea—Glipizide—type 2 diabetes mellitus	0.000304	0.00171	CcSEcCtD
Meprobamate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000303	0.00171	CcSEcCtD
Meprobamate—Hypotension—Valsartan—type 2 diabetes mellitus	0.000303	0.00171	CcSEcCtD
Meprobamate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000303	0.0017	CcSEcCtD
Meprobamate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000301	0.00169	CcSEcCtD
Meprobamate—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000301	0.00169	CcSEcCtD
Meprobamate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.0003	0.00169	CcSEcCtD
Meprobamate—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.0003	0.00169	CcSEcCtD
Meprobamate—Headache—Glimepiride—type 2 diabetes mellitus	0.000299	0.00169	CcSEcCtD
Meprobamate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000298	0.00168	CcSEcCtD
Meprobamate—Agitation—Losartan—type 2 diabetes mellitus	0.000296	0.00167	CcSEcCtD
Meprobamate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000295	0.00166	CcSEcCtD
Meprobamate—Angioedema—Losartan—type 2 diabetes mellitus	0.000294	0.00166	CcSEcCtD
Meprobamate—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000292	0.00164	CcSEcCtD
Meprobamate—Shock—Metformin—type 2 diabetes mellitus	0.000291	0.00164	CcSEcCtD
Meprobamate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00029	0.00163	CcSEcCtD
Meprobamate—Vertigo—Losartan—type 2 diabetes mellitus	0.000289	0.00163	CcSEcCtD
Meprobamate—Somnolence—Valsartan—type 2 diabetes mellitus	0.000289	0.00163	CcSEcCtD
Meprobamate—Syncope—Losartan—type 2 diabetes mellitus	0.000289	0.00163	CcSEcCtD
Meprobamate—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000288	0.00162	CcSEcCtD
Meprobamate—Leukopenia—Losartan—type 2 diabetes mellitus	0.000288	0.00162	CcSEcCtD
Meprobamate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000285	0.0016	CcSEcCtD
Meprobamate—Palpitations—Losartan—type 2 diabetes mellitus	0.000284	0.0016	CcSEcCtD
Meprobamate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000284	0.0016	CcSEcCtD
Meprobamate—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000283	0.0016	CcSEcCtD
Meprobamate—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000283	0.00159	CcSEcCtD
Meprobamate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000283	0.00159	CcSEcCtD
Meprobamate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000282	0.00159	CcSEcCtD
Meprobamate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000279	0.00157	CcSEcCtD
Meprobamate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000279	0.00157	CcSEcCtD
Meprobamate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000278	0.00157	CcSEcCtD
Meprobamate—Hypotension—Metformin—type 2 diabetes mellitus	0.000276	0.00156	CcSEcCtD
Meprobamate—Shock—Irbesartan—type 2 diabetes mellitus	0.000275	0.00155	CcSEcCtD
Meprobamate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000274	0.00154	CcSEcCtD
Meprobamate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000272	0.00153	CcSEcCtD
Meprobamate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000271	0.00153	CcSEcCtD
Meprobamate—Headache—Bromocriptine—type 2 diabetes mellitus	0.00027	0.00152	CcSEcCtD
Meprobamate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000269	0.00152	CcSEcCtD
Meprobamate—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000266	0.0015	CcSEcCtD
Meprobamate—Somnolence—Metformin—type 2 diabetes mellitus	0.000263	0.00148	CcSEcCtD
Meprobamate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000263	0.00148	CcSEcCtD
Meprobamate—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000261	0.00147	CcSEcCtD
Meprobamate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00026	0.00147	CcSEcCtD
Meprobamate—Shock—Losartan—type 2 diabetes mellitus	0.000258	0.00146	CcSEcCtD
Meprobamate—Tachycardia—Losartan—type 2 diabetes mellitus	0.000256	0.00144	CcSEcCtD
Meprobamate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000256	0.00144	CcSEcCtD
Meprobamate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000254	0.00143	CcSEcCtD
Meprobamate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000254	0.00143	CcSEcCtD
Meprobamate—Agitation—Ramipril—type 2 diabetes mellitus	0.000254	0.00143	CcSEcCtD
Meprobamate—Angioedema—Ramipril—type 2 diabetes mellitus	0.000252	0.00142	CcSEcCtD
Meprobamate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000251	0.00141	CcSEcCtD
Meprobamate—Vomiting—Glyburide—type 2 diabetes mellitus	0.00025	0.00141	CcSEcCtD
Meprobamate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00025	0.00141	CcSEcCtD
Meprobamate—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000248	0.0014	CcSEcCtD
Meprobamate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000248	0.0014	CcSEcCtD
Meprobamate—Vertigo—Ramipril—type 2 diabetes mellitus	0.000248	0.0014	CcSEcCtD
Meprobamate—Syncope—Ramipril—type 2 diabetes mellitus	0.000247	0.00139	CcSEcCtD
Meprobamate—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000247	0.00139	CcSEcCtD
Meprobamate—Headache—Glyburide—type 2 diabetes mellitus	0.000247	0.00139	CcSEcCtD
Meprobamate—Hypotension—Losartan—type 2 diabetes mellitus	0.000245	0.00138	CcSEcCtD
Meprobamate—Palpitations—Ramipril—type 2 diabetes mellitus	0.000244	0.00137	CcSEcCtD
Meprobamate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000243	0.00137	CcSEcCtD
Meprobamate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000242	0.00136	CcSEcCtD
Meprobamate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000239	0.00135	CcSEcCtD
Meprobamate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000236	0.00133	CcSEcCtD
Meprobamate—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000236	0.00133	CcSEcCtD
Meprobamate—Nausea—Glyburide—type 2 diabetes mellitus	0.000234	0.00132	CcSEcCtD
Meprobamate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000234	0.00132	CcSEcCtD
Meprobamate—Somnolence—Losartan—type 2 diabetes mellitus	0.000233	0.00132	CcSEcCtD
Meprobamate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000233	0.00131	CcSEcCtD
Meprobamate—Asthenia—Orlistat—type 2 diabetes mellitus	0.00023	0.0013	CcSEcCtD
Meprobamate—Pruritus—Valsartan—type 2 diabetes mellitus	0.00023	0.00129	CcSEcCtD
Meprobamate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000227	0.00128	CcSEcCtD
Meprobamate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000225	0.00127	CcSEcCtD
Meprobamate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000225	0.00127	CcSEcCtD
Meprobamate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000223	0.00125	CcSEcCtD
Meprobamate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000222	0.00125	CcSEcCtD
Meprobamate—Shock—Ramipril—type 2 diabetes mellitus	0.000222	0.00125	CcSEcCtD
Meprobamate—Headache—Gliclazide—type 2 diabetes mellitus	0.000221	0.00125	CcSEcCtD
Meprobamate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000221	0.00124	CcSEcCtD
Meprobamate—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00022	0.00124	CcSEcCtD
Meprobamate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00022	0.00124	CcSEcCtD
Meprobamate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000215	0.00121	CcSEcCtD
Meprobamate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000212	0.0012	CcSEcCtD
Meprobamate—Asthenia—Metformin—type 2 diabetes mellitus	0.000212	0.0012	CcSEcCtD
Meprobamate—Hypotension—Ramipril—type 2 diabetes mellitus	0.00021	0.00119	CcSEcCtD
Meprobamate—Nausea—Gliclazide—type 2 diabetes mellitus	0.00021	0.00118	CcSEcCtD
Meprobamate—Pruritus—Metformin—type 2 diabetes mellitus	0.000209	0.00118	CcSEcCtD
Meprobamate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000208	0.00117	CcSEcCtD
Meprobamate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000206	0.00116	CcSEcCtD
Meprobamate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000206	0.00116	CcSEcCtD
Meprobamate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000205	0.00115	CcSEcCtD
Meprobamate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000204	0.00115	CcSEcCtD
Meprobamate—Headache—Valsartan—type 2 diabetes mellitus	0.000203	0.00115	CcSEcCtD
Meprobamate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000202	0.00114	CcSEcCtD
Meprobamate—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000202	0.00114	CcSEcCtD
Meprobamate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000202	0.00114	CcSEcCtD
Meprobamate—Headache—Orlistat—type 2 diabetes mellitus	0.000201	0.00113	CcSEcCtD
Meprobamate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.0002	0.00113	CcSEcCtD
Meprobamate—Somnolence—Ramipril—type 2 diabetes mellitus	0.0002	0.00113	CcSEcCtD
Meprobamate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000197	0.00111	CcSEcCtD
Meprobamate—Dizziness—Metformin—type 2 diabetes mellitus	0.000196	0.0011	CcSEcCtD
Meprobamate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000193	0.00109	CcSEcCtD
Meprobamate—Nausea—Valsartan—type 2 diabetes mellitus	0.000193	0.00109	CcSEcCtD
Meprobamate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000191	0.00108	CcSEcCtD
Meprobamate—Nausea—Orlistat—type 2 diabetes mellitus	0.000191	0.00107	CcSEcCtD
Meprobamate—Asthenia—Losartan—type 2 diabetes mellitus	0.000188	0.00106	CcSEcCtD
Meprobamate—Vomiting—Metformin—type 2 diabetes mellitus	0.000188	0.00106	CcSEcCtD
Meprobamate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000186	0.00105	CcSEcCtD
Meprobamate—Pruritus—Losartan—type 2 diabetes mellitus	0.000186	0.00105	CcSEcCtD
Meprobamate—Headache—Metformin—type 2 diabetes mellitus	0.000185	0.00104	CcSEcCtD
Meprobamate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000185	0.00104	CcSEcCtD
Meprobamate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00018	0.00101	CcSEcCtD
Meprobamate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000178	0.001	CcSEcCtD
Meprobamate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000177	0.001	CcSEcCtD
Meprobamate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000176	0.000991	CcSEcCtD
Meprobamate—Nausea—Metformin—type 2 diabetes mellitus	0.000176	0.00099	CcSEcCtD
Meprobamate—Headache—Irbesartan—type 2 diabetes mellitus	0.000175	0.000985	CcSEcCtD
Meprobamate—Dizziness—Losartan—type 2 diabetes mellitus	0.000174	0.000979	CcSEcCtD
Meprobamate—Vomiting—Losartan—type 2 diabetes mellitus	0.000167	0.000941	CcSEcCtD
Meprobamate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000166	0.000935	CcSEcCtD
Meprobamate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000166	0.000934	CcSEcCtD
Meprobamate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000165	0.000932	CcSEcCtD
Meprobamate—Headache—Losartan—type 2 diabetes mellitus	0.000165	0.000927	CcSEcCtD
Meprobamate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000162	0.000911	CcSEcCtD
Meprobamate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000159	0.000898	CcSEcCtD
Meprobamate—Nausea—Losartan—type 2 diabetes mellitus	0.000156	0.000879	CcSEcCtD
Meprobamate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000154	0.000868	CcSEcCtD
Meprobamate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000149	0.000839	CcSEcCtD
Meprobamate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000143	0.000807	CcSEcCtD
Meprobamate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000142	0.000799	CcSEcCtD
Meprobamate—Headache—Ramipril—type 2 diabetes mellitus	0.000141	0.000795	CcSEcCtD
Meprobamate—Nausea—Ramipril—type 2 diabetes mellitus	0.000134	0.000754	CcSEcCtD
Meprobamate—CYP2E1—Metabolism—COX2—type 2 diabetes mellitus	1.85e-05	0.000212	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.85e-05	0.000212	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.84e-05	0.000211	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	1.84e-05	0.00021	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	1.84e-05	0.00021	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.82e-05	0.000209	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ENPP1—type 2 diabetes mellitus	1.82e-05	0.000208	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ND1—type 2 diabetes mellitus	1.82e-05	0.000208	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.82e-05	0.000208	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—G6PC—type 2 diabetes mellitus	1.82e-05	0.000208	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HBA2—type 2 diabetes mellitus	1.82e-05	0.000208	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.82e-05	0.000208	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NCOA6—type 2 diabetes mellitus	1.82e-05	0.000208	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.81e-05	0.000207	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	1.8e-05	0.000206	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—UCP2—type 2 diabetes mellitus	1.79e-05	0.000205	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.79e-05	0.000205	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—UCP3—type 2 diabetes mellitus	1.79e-05	0.000205	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.78e-05	0.000203	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	1.78e-05	0.000203	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	1.78e-05	0.000203	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	1.78e-05	0.000203	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	1.78e-05	0.000203	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.77e-05	0.000203	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GCGR—type 2 diabetes mellitus	1.76e-05	0.000202	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	1.72e-05	0.000197	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	1.71e-05	0.000196	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.7e-05	0.000194	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PCK1—type 2 diabetes mellitus	1.68e-05	0.000192	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—OXCT1—type 2 diabetes mellitus	1.66e-05	0.00019	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYTB—type 2 diabetes mellitus	1.66e-05	0.00019	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.65e-05	0.000189	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.62e-05	0.000186	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.62e-05	0.000186	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SRD5A1—type 2 diabetes mellitus	1.62e-05	0.000186	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.59e-05	0.000182	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.58e-05	0.000181	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.57e-05	0.00018	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HK1—type 2 diabetes mellitus	1.57e-05	0.00018	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.55e-05	0.000177	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—STAR—type 2 diabetes mellitus	1.55e-05	0.000177	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HSD17B3—type 2 diabetes mellitus	1.55e-05	0.000177	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ACACA—type 2 diabetes mellitus	1.55e-05	0.000177	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GCKR—type 2 diabetes mellitus	1.52e-05	0.000174	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.52e-05	0.000174	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—LPA—type 2 diabetes mellitus	1.52e-05	0.000174	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.52e-05	0.000174	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.51e-05	0.000173	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.51e-05	0.000173	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.51e-05	0.000173	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.51e-05	0.000173	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.49e-05	0.00017	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CBS—type 2 diabetes mellitus	1.48e-05	0.00017	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ABCC8—type 2 diabetes mellitus	1.48e-05	0.00017	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ALDOB—type 2 diabetes mellitus	1.46e-05	0.000167	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.45e-05	0.000166	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.45e-05	0.000166	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	1.43e-05	0.000163	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	1.43e-05	0.000163	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	1.4e-05	0.00016	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.4e-05	0.00016	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.39e-05	0.000159	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.39e-05	0.000159	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.39e-05	0.000159	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	1.38e-05	0.000158	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	1.38e-05	0.000158	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	1.38e-05	0.000158	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.37e-05	0.000157	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GLP1R—type 2 diabetes mellitus	1.35e-05	0.000155	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.35e-05	0.000154	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.35e-05	0.000154	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.35e-05	0.000154	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.35e-05	0.000154	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.34e-05	0.000153	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.3e-05	0.000149	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	1.3e-05	0.000148	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.29e-05	0.000148	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.28e-05	0.000147	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.28e-05	0.000146	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.27e-05	0.000145	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.26e-05	0.000145	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.24e-05	0.000142	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.24e-05	0.000142	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CPT1A—type 2 diabetes mellitus	1.24e-05	0.000142	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—MTR—type 2 diabetes mellitus	1.24e-05	0.000142	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.24e-05	0.000142	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NAMPT—type 2 diabetes mellitus	1.21e-05	0.000139	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.21e-05	0.000139	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	1.21e-05	0.000139	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.21e-05	0.000139	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GCK—type 2 diabetes mellitus	1.21e-05	0.000138	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—LIPC—type 2 diabetes mellitus	1.21e-05	0.000138	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HBA1—type 2 diabetes mellitus	1.21e-05	0.000138	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.2e-05	0.000137	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.18e-05	0.000136	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.18e-05	0.000135	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	1.17e-05	0.000134	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	1.17e-05	0.000134	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	1.17e-05	0.000134	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	1.17e-05	0.000134	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	1.16e-05	0.000133	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.16e-05	0.000133	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.16e-05	0.000132	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.14e-05	0.000131	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.14e-05	0.000131	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.14e-05	0.000131	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.14e-05	0.000131	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.13e-05	0.000129	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	1.12e-05	0.000129	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.1e-05	0.000126	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.09e-05	0.000125	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	1.08e-05	0.000124	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	1.08e-05	0.000124	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	1.08e-05	0.000124	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.07e-05	0.000122	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	1.06e-05	0.000122	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.06e-05	0.000121	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	1.05e-05	0.000121	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.05e-05	0.00012	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	1.04e-05	0.00012	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.03e-05	0.000118	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.02e-05	0.000117	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.81e-06	0.000112	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	9.79e-06	0.000112	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	9.79e-06	0.000112	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	9.75e-06	0.000112	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	9.56e-06	0.000109	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	9.56e-06	0.000109	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.55e-06	0.000109	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	9.52e-06	0.000109	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	9.39e-06	0.000107	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.39e-06	0.000107	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	9.37e-06	0.000107	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	9.33e-06	0.000107	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	9.33e-06	0.000107	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	9.32e-06	0.000107	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	9.31e-06	0.000107	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	9.31e-06	0.000107	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	9.31e-06	0.000107	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	9.26e-06	0.000106	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	9.15e-06	0.000105	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	9.09e-06	0.000104	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	9.09e-06	0.000104	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	9.09e-06	0.000104	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	9.09e-06	0.000104	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	9.03e-06	0.000103	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	8.98e-06	0.000103	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	8.87e-06	0.000102	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	8.77e-06	0.0001	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.61e-06	9.85e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.38e-06	9.59e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	8.35e-06	9.56e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	8.35e-06	9.56e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	8.35e-06	9.56e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	8.2e-06	9.38e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	8.15e-06	9.33e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	8.15e-06	9.33e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	8.15e-06	9.33e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	8.13e-06	9.3e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.09e-06	9.26e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	8.09e-06	9.26e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	8.05e-06	9.22e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	8.01e-06	9.17e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	8e-06	9.16e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	7.95e-06	9.1e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	7.95e-06	9.09e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	7.93e-06	9.08e-05	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.77e-06	8.9e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	7.76e-06	8.88e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	7.71e-06	8.83e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	7.64e-06	8.74e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	7.55e-06	8.64e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	7.55e-06	8.64e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	7.5e-06	8.59e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	7.46e-06	8.53e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.37e-06	8.44e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.37e-06	8.44e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	7.37e-06	8.43e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	7.37e-06	8.43e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.33e-06	8.39e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	7.24e-06	8.29e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	7.24e-06	8.29e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	7.21e-06	8.25e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.19e-06	8.23e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	7.19e-06	8.22e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	7.07e-06	8.09e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.07e-06	8.09e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	7e-06	8.01e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.91e-06	7.91e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	6.63e-06	7.59e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	6.51e-06	7.45e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	6.3e-06	7.21e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	6.24e-06	7.14e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.24e-06	7.14e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	6.21e-06	7.11e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	6.2e-06	7.09e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	6.17e-06	7.07e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	6.13e-06	7.02e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	6.1e-06	6.98e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.09e-06	6.97e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	6.09e-06	6.97e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	6.06e-06	6.94e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5.98e-06	6.85e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	5.95e-06	6.81e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	5.81e-06	6.65e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	5.79e-06	6.63e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	5.68e-06	6.5e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.65e-06	6.47e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	5.56e-06	6.37e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	5.55e-06	6.35e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	5.54e-06	6.35e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	5.43e-06	6.21e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.41e-06	6.19e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	5.4e-06	6.18e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	5.38e-06	6.15e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	5.33e-06	6.1e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	5.27e-06	6.04e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.27e-06	6.03e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.2e-06	5.96e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	5.12e-06	5.86e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	5.02e-06	5.74e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.99e-06	5.72e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.9e-06	5.61e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	4.86e-06	5.56e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	4.84e-06	5.53e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	4.78e-06	5.47e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	4.76e-06	5.45e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.75e-06	5.43e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	4.71e-06	5.39e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.67e-06	5.34e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.65e-06	5.32e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.63e-06	5.29e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	4.63e-06	5.29e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.6e-06	5.26e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	4.23e-06	4.84e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	4.15e-06	4.75e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	4.07e-06	4.66e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.05e-06	4.63e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.97e-06	4.55e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.73e-06	4.27e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.64e-06	4.17e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	3.57e-06	4.08e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	3.57e-06	4.08e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.48e-06	3.99e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.48e-06	3.99e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	3.26e-06	3.74e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.19e-06	3.65e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	2.13e-06	2.43e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.64e-06	1.88e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.6e-06	1.83e-05	CbGpPWpGaD
